Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years
Main, C; Shepherd, J; Anderson, R; et al.Rogers, G; Thompson-Coon, Jo; Liu, Z; Hartwell, D; Loveman, E; Green, C; Pitt, M; Stein, Ken; Harris, P; Frampton, GK; Smith, M; Takeda, A; Price, A; Welch, K; Somerville, M
Date: 1 May 2008
Journal
Health Technology Assessment
Publisher
NIHR Health Technology Assessment Programme
Publisher DOI
Related links
Abstract
To assess the clinical and cost-effectiveness of inhaled corticosteroids (ICS) alone and ICS used in combination with a long-acting beta2 agonist (LABA) in the treatment of chronic asthma in children aged under 12 years.
Institute of Health Research
Collections of Former Colleges
Item views 0
Full item downloads 0